Management of patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: 1-year outcomes of the PERI-DYS study

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2023-08, Vol.379, p.S42
Main Authors: Parhofer, K., Pittrow, D., Birkenfeld, A., Fraass, U., Hohenstein, B., Siegert, C., Klotsche, J., Steinhagen-Thiessen, E., Dexl, S., Schettler, V., Laufs, U.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
DOI:10.1016/j.atherosclerosis.2023.06.800